Global New Shingles Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global New Shingles Vaccine market size was valued at US$ 1266 million in 2024 and is forecast to a readjusted size of USD 1594 million by 2031 with a CAGR of 3.4% during review period.
The new shingles vaccine is a vaccine used to prevent herpes zoster (commonly known as 'shingles'), which mainly stimulates the immune system to produce antibodies against the varicella-zoster virus (VZV), thereby reducing the risk of shingles infection in the elderly and those with weakened immunity, and reducing the pain and complications caused by the disease. This vaccine usually contains highly effective active ingredients that can significantly enhance the body's immune response, is more effective than traditional vaccines, and can provide long-term protection, especially for people over 50 years old.
This report is a detailed and comprehensive analysis for global New Shingles Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global New Shingles Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for New Shingles Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global New Shingles Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, Merck, Sanofi, Novartis, Yidao Biotechnology, Jiangsu Ruike Biotechnology, Beijing Luzhu Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
New Shingles Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe New Shingles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of New Shingles Vaccine, with price, sales quantity, revenue, and global market share of New Shingles Vaccine from 2020 to 2025.
Chapter 3, the New Shingles Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the New Shingles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and New Shingles Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of New Shingles Vaccine.
Chapter 14 and 15, to describe New Shingles Vaccine sales channel, distributors, customers, research findings and conclusion.
The new shingles vaccine is a vaccine used to prevent herpes zoster (commonly known as 'shingles'), which mainly stimulates the immune system to produce antibodies against the varicella-zoster virus (VZV), thereby reducing the risk of shingles infection in the elderly and those with weakened immunity, and reducing the pain and complications caused by the disease. This vaccine usually contains highly effective active ingredients that can significantly enhance the body's immune response, is more effective than traditional vaccines, and can provide long-term protection, especially for people over 50 years old.
This report is a detailed and comprehensive analysis for global New Shingles Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global New Shingles Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global New Shingles Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for New Shingles Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global New Shingles Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, Merck, Sanofi, Novartis, Yidao Biotechnology, Jiangsu Ruike Biotechnology, Beijing Luzhu Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
New Shingles Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Live Attenuated Vaccines
- Recombinant Vaccines
- Subcutaneous Vaccines
- Intradermal Vaccines
- Pfizer
- GSK
- Merck
- Sanofi
- Novartis
- Yidao Biotechnology
- Jiangsu Ruike Biotechnology
- Beijing Luzhu Biotechnology
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe New Shingles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of New Shingles Vaccine, with price, sales quantity, revenue, and global market share of New Shingles Vaccine from 2020 to 2025.
Chapter 3, the New Shingles Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the New Shingles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and New Shingles Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of New Shingles Vaccine.
Chapter 14 and 15, to describe New Shingles Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global New Shingles Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Live Attenuated Vaccines
1.3.3 Recombinant Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global New Shingles Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Subcutaneous Vaccines
1.4.3 Intradermal Vaccines
1.5 Global New Shingles Vaccine Market Size & Forecast
1.5.1 Global New Shingles Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global New Shingles Vaccine Sales Quantity (2020-2031)
1.5.3 Global New Shingles Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer New Shingles Vaccine Product and Services
2.1.4 Pfizer New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK New Shingles Vaccine Product and Services
2.2.4 GSK New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GSK Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck New Shingles Vaccine Product and Services
2.3.4 Merck New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi New Shingles Vaccine Product and Services
2.4.4 Sanofi New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sanofi Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis New Shingles Vaccine Product and Services
2.5.4 Novartis New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments/Updates
2.6 Yidao Biotechnology
2.6.1 Yidao Biotechnology Details
2.6.2 Yidao Biotechnology Major Business
2.6.3 Yidao Biotechnology New Shingles Vaccine Product and Services
2.6.4 Yidao Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Yidao Biotechnology Recent Developments/Updates
2.7 Jiangsu Ruike Biotechnology
2.7.1 Jiangsu Ruike Biotechnology Details
2.7.2 Jiangsu Ruike Biotechnology Major Business
2.7.3 Jiangsu Ruike Biotechnology New Shingles Vaccine Product and Services
2.7.4 Jiangsu Ruike Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Jiangsu Ruike Biotechnology Recent Developments/Updates
2.8 Beijing Luzhu Biotechnology
2.8.1 Beijing Luzhu Biotechnology Details
2.8.2 Beijing Luzhu Biotechnology Major Business
2.8.3 Beijing Luzhu Biotechnology New Shingles Vaccine Product and Services
2.8.4 Beijing Luzhu Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Beijing Luzhu Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEW SHINGLES VACCINE BY MANUFACTURER
3.1 Global New Shingles Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global New Shingles Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global New Shingles Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of New Shingles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 New Shingles Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 New Shingles Vaccine Manufacturer Market Share in 2024
3.5 New Shingles Vaccine Market: Overall Company Footprint Analysis
3.5.1 New Shingles Vaccine Market: Region Footprint
3.5.2 New Shingles Vaccine Market: Company Product Type Footprint
3.5.3 New Shingles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global New Shingles Vaccine Market Size by Region
4.1.1 Global New Shingles Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global New Shingles Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global New Shingles Vaccine Average Price by Region (2020-2031)
4.2 North America New Shingles Vaccine Consumption Value (2020-2031)
4.3 Europe New Shingles Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific New Shingles Vaccine Consumption Value (2020-2031)
4.5 South America New Shingles Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa New Shingles Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global New Shingles Vaccine Sales Quantity by Type (2020-2031)
5.2 Global New Shingles Vaccine Consumption Value by Type (2020-2031)
5.3 Global New Shingles Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global New Shingles Vaccine Sales Quantity by Application (2020-2031)
6.2 Global New Shingles Vaccine Consumption Value by Application (2020-2031)
6.3 Global New Shingles Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America New Shingles Vaccine Sales Quantity by Type (2020-2031)
7.2 North America New Shingles Vaccine Sales Quantity by Application (2020-2031)
7.3 North America New Shingles Vaccine Market Size by Country
7.3.1 North America New Shingles Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America New Shingles Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe New Shingles Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe New Shingles Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe New Shingles Vaccine Market Size by Country
8.3.1 Europe New Shingles Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe New Shingles Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific New Shingles Vaccine Market Size by Region
9.3.1 Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific New Shingles Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America New Shingles Vaccine Sales Quantity by Type (2020-2031)
10.2 South America New Shingles Vaccine Sales Quantity by Application (2020-2031)
10.3 South America New Shingles Vaccine Market Size by Country
10.3.1 South America New Shingles Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America New Shingles Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa New Shingles Vaccine Market Size by Country
11.3.1 Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa New Shingles Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 New Shingles Vaccine Market Drivers
12.2 New Shingles Vaccine Market Restraints
12.3 New Shingles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of New Shingles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of New Shingles Vaccine
13.3 New Shingles Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 New Shingles Vaccine Typical Distributors
14.3 New Shingles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global New Shingles Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Live Attenuated Vaccines
1.3.3 Recombinant Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global New Shingles Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Subcutaneous Vaccines
1.4.3 Intradermal Vaccines
1.5 Global New Shingles Vaccine Market Size & Forecast
1.5.1 Global New Shingles Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global New Shingles Vaccine Sales Quantity (2020-2031)
1.5.3 Global New Shingles Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer New Shingles Vaccine Product and Services
2.1.4 Pfizer New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK New Shingles Vaccine Product and Services
2.2.4 GSK New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GSK Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck New Shingles Vaccine Product and Services
2.3.4 Merck New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi New Shingles Vaccine Product and Services
2.4.4 Sanofi New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sanofi Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis New Shingles Vaccine Product and Services
2.5.4 Novartis New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments/Updates
2.6 Yidao Biotechnology
2.6.1 Yidao Biotechnology Details
2.6.2 Yidao Biotechnology Major Business
2.6.3 Yidao Biotechnology New Shingles Vaccine Product and Services
2.6.4 Yidao Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Yidao Biotechnology Recent Developments/Updates
2.7 Jiangsu Ruike Biotechnology
2.7.1 Jiangsu Ruike Biotechnology Details
2.7.2 Jiangsu Ruike Biotechnology Major Business
2.7.3 Jiangsu Ruike Biotechnology New Shingles Vaccine Product and Services
2.7.4 Jiangsu Ruike Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Jiangsu Ruike Biotechnology Recent Developments/Updates
2.8 Beijing Luzhu Biotechnology
2.8.1 Beijing Luzhu Biotechnology Details
2.8.2 Beijing Luzhu Biotechnology Major Business
2.8.3 Beijing Luzhu Biotechnology New Shingles Vaccine Product and Services
2.8.4 Beijing Luzhu Biotechnology New Shingles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Beijing Luzhu Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEW SHINGLES VACCINE BY MANUFACTURER
3.1 Global New Shingles Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global New Shingles Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global New Shingles Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of New Shingles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 New Shingles Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 New Shingles Vaccine Manufacturer Market Share in 2024
3.5 New Shingles Vaccine Market: Overall Company Footprint Analysis
3.5.1 New Shingles Vaccine Market: Region Footprint
3.5.2 New Shingles Vaccine Market: Company Product Type Footprint
3.5.3 New Shingles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global New Shingles Vaccine Market Size by Region
4.1.1 Global New Shingles Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global New Shingles Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global New Shingles Vaccine Average Price by Region (2020-2031)
4.2 North America New Shingles Vaccine Consumption Value (2020-2031)
4.3 Europe New Shingles Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific New Shingles Vaccine Consumption Value (2020-2031)
4.5 South America New Shingles Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa New Shingles Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global New Shingles Vaccine Sales Quantity by Type (2020-2031)
5.2 Global New Shingles Vaccine Consumption Value by Type (2020-2031)
5.3 Global New Shingles Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global New Shingles Vaccine Sales Quantity by Application (2020-2031)
6.2 Global New Shingles Vaccine Consumption Value by Application (2020-2031)
6.3 Global New Shingles Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America New Shingles Vaccine Sales Quantity by Type (2020-2031)
7.2 North America New Shingles Vaccine Sales Quantity by Application (2020-2031)
7.3 North America New Shingles Vaccine Market Size by Country
7.3.1 North America New Shingles Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America New Shingles Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe New Shingles Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe New Shingles Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe New Shingles Vaccine Market Size by Country
8.3.1 Europe New Shingles Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe New Shingles Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific New Shingles Vaccine Market Size by Region
9.3.1 Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific New Shingles Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America New Shingles Vaccine Sales Quantity by Type (2020-2031)
10.2 South America New Shingles Vaccine Sales Quantity by Application (2020-2031)
10.3 South America New Shingles Vaccine Market Size by Country
10.3.1 South America New Shingles Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America New Shingles Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa New Shingles Vaccine Market Size by Country
11.3.1 Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa New Shingles Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 New Shingles Vaccine Market Drivers
12.2 New Shingles Vaccine Market Restraints
12.3 New Shingles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of New Shingles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of New Shingles Vaccine
13.3 New Shingles Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 New Shingles Vaccine Typical Distributors
14.3 New Shingles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global New Shingles Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global New Shingles Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer New Shingles Vaccine Product and Services
Table 6. Pfizer New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK New Shingles Vaccine Product and Services
Table 11. GSK New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GSK Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck New Shingles Vaccine Product and Services
Table 16. Merck New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi New Shingles Vaccine Product and Services
Table 21. Sanofi New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sanofi Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis New Shingles Vaccine Product and Services
Table 26. Novartis New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Novartis Recent Developments/Updates
Table 28. Yidao Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. Yidao Biotechnology Major Business
Table 30. Yidao Biotechnology New Shingles Vaccine Product and Services
Table 31. Yidao Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Yidao Biotechnology Recent Developments/Updates
Table 33. Jiangsu Ruike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Ruike Biotechnology Major Business
Table 35. Jiangsu Ruike Biotechnology New Shingles Vaccine Product and Services
Table 36. Jiangsu Ruike Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Jiangsu Ruike Biotechnology Recent Developments/Updates
Table 38. Beijing Luzhu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Beijing Luzhu Biotechnology Major Business
Table 40. Beijing Luzhu Biotechnology New Shingles Vaccine Product and Services
Table 41. Beijing Luzhu Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Beijing Luzhu Biotechnology Recent Developments/Updates
Table 43. Global New Shingles Vaccine Sales Quantity by Manufacturer (2020-2025) & (Units)
Table 44. Global New Shingles Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. Global New Shingles Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 46. Market Position of Manufacturers in New Shingles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 47. Head Office and New Shingles Vaccine Production Site of Key Manufacturer
Table 48. New Shingles Vaccine Market: Company Product Type Footprint
Table 49. New Shingles Vaccine Market: Company Product Application Footprint
Table 50. New Shingles Vaccine New Market Entrants and Barriers to Market Entry
Table 51. New Shingles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global New Shingles Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. Global New Shingles Vaccine Sales Quantity by Region (2020-2025) & (Units)
Table 54. Global New Shingles Vaccine Sales Quantity by Region (2026-2031) & (Units)
Table 55. Global New Shingles Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 56. Global New Shingles Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 57. Global New Shingles Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 58. Global New Shingles Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 59. Global New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 60. Global New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 61. Global New Shingles Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 62. Global New Shingles Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 63. Global New Shingles Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 64. Global New Shingles Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 65. Global New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 66. Global New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 67. Global New Shingles Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 68. Global New Shingles Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 69. Global New Shingles Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 70. Global New Shingles Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 71. North America New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 72. North America New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 73. North America New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 74. North America New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 75. North America New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 76. North America New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 77. North America New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 80. Europe New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 81. Europe New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 82. Europe New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 83. Europe New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 84. Europe New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 85. Europe New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 86. Europe New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 88. Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 89. Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 90. Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 91. Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2020-2025) & (Units)
Table 92. Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2026-2031) & (Units)
Table 93. Asia-Pacific New Shingles Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-Pacific New Shingles Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South America New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 96. South America New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 97. South America New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 98. South America New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 99. South America New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 100. South America New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 101. South America New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South America New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 104. Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 105. Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 106. Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 107. Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 108. Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 109. Middle East & Africa New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & Africa New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 111. New Shingles Vaccine Raw Material
Table 112. Key Manufacturers of New Shingles Vaccine Raw Materials
Table 113. New Shingles Vaccine Typical Distributors
Table 114. New Shingles Vaccine Typical Customers
Table 1. Global New Shingles Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global New Shingles Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer New Shingles Vaccine Product and Services
Table 6. Pfizer New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK New Shingles Vaccine Product and Services
Table 11. GSK New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. GSK Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck New Shingles Vaccine Product and Services
Table 16. Merck New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi New Shingles Vaccine Product and Services
Table 21. Sanofi New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sanofi Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis New Shingles Vaccine Product and Services
Table 26. Novartis New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Novartis Recent Developments/Updates
Table 28. Yidao Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. Yidao Biotechnology Major Business
Table 30. Yidao Biotechnology New Shingles Vaccine Product and Services
Table 31. Yidao Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Yidao Biotechnology Recent Developments/Updates
Table 33. Jiangsu Ruike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Ruike Biotechnology Major Business
Table 35. Jiangsu Ruike Biotechnology New Shingles Vaccine Product and Services
Table 36. Jiangsu Ruike Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Jiangsu Ruike Biotechnology Recent Developments/Updates
Table 38. Beijing Luzhu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Beijing Luzhu Biotechnology Major Business
Table 40. Beijing Luzhu Biotechnology New Shingles Vaccine Product and Services
Table 41. Beijing Luzhu Biotechnology New Shingles Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Beijing Luzhu Biotechnology Recent Developments/Updates
Table 43. Global New Shingles Vaccine Sales Quantity by Manufacturer (2020-2025) & (Units)
Table 44. Global New Shingles Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. Global New Shingles Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 46. Market Position of Manufacturers in New Shingles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 47. Head Office and New Shingles Vaccine Production Site of Key Manufacturer
Table 48. New Shingles Vaccine Market: Company Product Type Footprint
Table 49. New Shingles Vaccine Market: Company Product Application Footprint
Table 50. New Shingles Vaccine New Market Entrants and Barriers to Market Entry
Table 51. New Shingles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global New Shingles Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. Global New Shingles Vaccine Sales Quantity by Region (2020-2025) & (Units)
Table 54. Global New Shingles Vaccine Sales Quantity by Region (2026-2031) & (Units)
Table 55. Global New Shingles Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 56. Global New Shingles Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 57. Global New Shingles Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 58. Global New Shingles Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 59. Global New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 60. Global New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 61. Global New Shingles Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 62. Global New Shingles Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 63. Global New Shingles Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 64. Global New Shingles Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 65. Global New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 66. Global New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 67. Global New Shingles Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 68. Global New Shingles Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 69. Global New Shingles Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 70. Global New Shingles Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 71. North America New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 72. North America New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 73. North America New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 74. North America New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 75. North America New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 76. North America New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 77. North America New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 80. Europe New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 81. Europe New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 82. Europe New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 83. Europe New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 84. Europe New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 85. Europe New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 86. Europe New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 88. Asia-Pacific New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 89. Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 90. Asia-Pacific New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 91. Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2020-2025) & (Units)
Table 92. Asia-Pacific New Shingles Vaccine Sales Quantity by Region (2026-2031) & (Units)
Table 93. Asia-Pacific New Shingles Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-Pacific New Shingles Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South America New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 96. South America New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 97. South America New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 98. South America New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 99. South America New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 100. South America New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 101. South America New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South America New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2020-2025) & (Units)
Table 104. Middle East & Africa New Shingles Vaccine Sales Quantity by Type (2026-2031) & (Units)
Table 105. Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2020-2025) & (Units)
Table 106. Middle East & Africa New Shingles Vaccine Sales Quantity by Application (2026-2031) & (Units)
Table 107. Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2020-2025) & (Units)
Table 108. Middle East & Africa New Shingles Vaccine Sales Quantity by Country (2026-2031) & (Units)
Table 109. Middle East & Africa New Shingles Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & Africa New Shingles Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 111. New Shingles Vaccine Raw Material
Table 112. Key Manufacturers of New Shingles Vaccine Raw Materials
Table 113. New Shingles Vaccine Typical Distributors
Table 114. New Shingles Vaccine Typical Customers
LIST OF FIGURES
Figure 1. New Shingles Vaccine Picture
Figure 2. Global New Shingles Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global New Shingles Vaccine Revenue Market Share by Type in 2024
Figure 4. Live Attenuated Vaccines Examples
Figure 5. Recombinant Vaccines Examples
Figure 6. Global New Shingles Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global New Shingles Vaccine Revenue Market Share by Application in 2024
Figure 8. Subcutaneous Vaccines Examples
Figure 9. Intradermal Vaccines Examples
Figure 10. Global New Shingles Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global New Shingles Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global New Shingles Vaccine Sales Quantity (2020-2031) & (Units)
Figure 13. Global New Shingles Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global New Shingles Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global New Shingles Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of New Shingles Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 New Shingles Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 New Shingles Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global New Shingles Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global New Shingles Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global New Shingles Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global New Shingles Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global New Shingles Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global New Shingles Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific New Shingles Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. New Shingles Vaccine Market Drivers
Figure 73. New Shingles Vaccine Market Restraints
Figure 74. New Shingles Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of New Shingles Vaccine in 2024
Figure 77. Manufacturing Process Analysis of New Shingles Vaccine
Figure 78. New Shingles Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. New Shingles Vaccine Picture
Figure 2. Global New Shingles Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global New Shingles Vaccine Revenue Market Share by Type in 2024
Figure 4. Live Attenuated Vaccines Examples
Figure 5. Recombinant Vaccines Examples
Figure 6. Global New Shingles Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global New Shingles Vaccine Revenue Market Share by Application in 2024
Figure 8. Subcutaneous Vaccines Examples
Figure 9. Intradermal Vaccines Examples
Figure 10. Global New Shingles Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global New Shingles Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global New Shingles Vaccine Sales Quantity (2020-2031) & (Units)
Figure 13. Global New Shingles Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global New Shingles Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global New Shingles Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of New Shingles Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 New Shingles Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 New Shingles Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global New Shingles Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global New Shingles Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global New Shingles Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global New Shingles Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global New Shingles Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global New Shingles Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific New Shingles Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific New Shingles Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa New Shingles Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa New Shingles Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa New Shingles Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. New Shingles Vaccine Market Drivers
Figure 73. New Shingles Vaccine Market Restraints
Figure 74. New Shingles Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of New Shingles Vaccine in 2024
Figure 77. Manufacturing Process Analysis of New Shingles Vaccine
Figure 78. New Shingles Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
